DE69300608D1 - Verwendung von L-Deprenyl zur Herstellung eines Arzneimittels zur Behandlung der Cushing's-Krankheit. - Google Patents

Verwendung von L-Deprenyl zur Herstellung eines Arzneimittels zur Behandlung der Cushing's-Krankheit.

Info

Publication number
DE69300608D1
DE69300608D1 DE69300608T DE69300608T DE69300608D1 DE 69300608 D1 DE69300608 D1 DE 69300608D1 DE 69300608 T DE69300608 T DE 69300608T DE 69300608 T DE69300608 T DE 69300608T DE 69300608 D1 DE69300608 D1 DE 69300608D1
Authority
DE
Germany
Prior art keywords
deprenyl
disease
medicament
manufacture
treat cushing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69300608T
Other languages
English (en)
Other versions
DE69300608T2 (de
Inventor
William Woodrow Ruehl
David Stewart Bruyette
David Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deprenyl Animal Health Inc
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Publication of DE69300608D1 publication Critical patent/DE69300608D1/de
Application granted granted Critical
Publication of DE69300608T2 publication Critical patent/DE69300608T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69300608T 1992-03-27 1993-01-22 Verwendung von L-Deprenyl zur Herstellung eines Arzneimittels zur Behandlung der Cushing's-Krankheit. Expired - Fee Related DE69300608T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/858,702 US5192808A (en) 1990-08-31 1992-03-27 Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)

Publications (2)

Publication Number Publication Date
DE69300608D1 true DE69300608D1 (de) 1995-11-16
DE69300608T2 DE69300608T2 (de) 1996-06-05

Family

ID=25328952

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69300608T Expired - Fee Related DE69300608T2 (de) 1992-03-27 1993-01-22 Verwendung von L-Deprenyl zur Herstellung eines Arzneimittels zur Behandlung der Cushing's-Krankheit.

Country Status (7)

Country Link
US (1) US5192808A (de)
EP (1) EP0562705B1 (de)
AT (1) ATE128865T1 (de)
DE (1) DE69300608T2 (de)
DK (1) DK0562705T3 (de)
ES (1) ES2082587T3 (de)
GR (1) GR3018657T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
DE69425345T2 (de) * 1993-05-04 2001-03-01 Ceva Sante Animale Libourne Anwendung von Selegilin in Tiermedizin
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
IL122484A0 (en) * 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DK0866691T4 (da) * 1995-11-06 2005-06-06 Somerset Pharmaceuticals Inc Medikamenter til sublingual og bukkal administration af selegilin
CA2290381A1 (en) 1997-05-21 1998-11-26 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
EP1565185A4 (de) * 2002-11-07 2011-01-05 Technion Res & Dev Foundation Neuroprotektive eisenchelatoren und pharmazeutische zusammensetzungen damit
EP1686973A4 (de) * 2003-11-25 2009-03-25 Technion Res & Dev Foundation Zusammensetzungen und verfahren zur behandlung von kardiovaskulären erkrankungen und krankheiten
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
PL2531181T3 (pl) 2010-02-03 2019-09-30 Pharma Two B Ltd. Preparaty rasagiliny o przedłużonym uwalnianiu i ich zastosowanie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects

Also Published As

Publication number Publication date
ES2082587T3 (es) 1996-03-16
EP0562705A1 (de) 1993-09-29
EP0562705B1 (de) 1995-10-11
DE69300608T2 (de) 1996-06-05
DK0562705T3 (da) 1996-02-19
US5192808A (en) 1993-03-09
GR3018657T3 (en) 1996-04-30
ATE128865T1 (de) 1995-10-15

Similar Documents

Publication Publication Date Title
DE69300608T2 (de) Verwendung von L-Deprenyl zur Herstellung eines Arzneimittels zur Behandlung der Cushing's-Krankheit.
ATE271874T1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
ATE181501T1 (de) Verwendung von l-deprenyl zur hemmung des alterniedergangs des immunsystems in säugetieren
DE69012261T2 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
EP0308197A3 (de) Verfahren zur Stimulierung des Immunsystems
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
CA2230307A1 (en) Aquatic animal treatment method and composition containing cajeput oil
DE69331546D1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ES2110550T3 (es) Tratamiento de la carne o del pescado.
US5547995B1 (en) Use of selegiline in veterinary medicine
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69424415T2 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
FR2708202B1 (fr) Implant biocompatible pour l'expression chez l'homme ou chez l'animal de substances déterminées.
DE69516602T2 (de) Verwendung von Bifemelan zur Herstellung eines Arzneimittels zur Behandlung der Hyperkinesie
CA2170289A1 (en) A method of treating liver disease and like indications with vasodilating agents
RU93033105A (ru) Способ лечения острых вирусных заболеваний животных отряда псовых
Huter Der Einfluss vou Diclazuril auf verschiedene Leistungsparameter bei der Japanischen Wachtel (Coturnix coturnix japonica)
DE69116452T2 (de) Verwendung von 3-Oxygermylpropionsäure zur Behandlung des Erkältungssyndroms
AU124532S (en) Horse belly rug
DE69426997T2 (de) Die Verwendung eines Calciumpräparates in einem Medikament zur Behandlung von an Hypocalcämie leidenden Milchkühen
UA12753A (uk) Спосіб лікуваhhя та профілактики респіраторhих захворюваhь молодhяка сільськогосподарських твариh змішаhої етіології
RU93029530A (ru) Средство для повышения интенсивности роста и сохранности молодняка-тимоцеол
RU92011168A (ru) Препарат для лечения гинекологических заболеваний

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee